Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast cream (ARQ-151) Phase 2b in chronic plaque psoriasis
NCT03638258Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Sep 2018
- Primary completion
- May 2019
- Countries
- 2
01
Overview
A Phase 2 trial of roflumilast vehicle cream in plaque psoriasis, sponsored by Arcutis Biotherapeutics. Started Sep 2018; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03638258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638258.